Etonogestrel Patent Expiration
Etonogestrel is Used for contraception. It was first introduced by Organon Usa Llc
Etonogestrel Patents
Given below is the list of patents protecting Etonogestrel, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Implanon | US9757552 | Applicator for inserting an implant | Jul 28, 2030 | Organon |
| Nexplanon | US9757552 | Applicator for inserting an implant | Jul 28, 2030 | Organon |
| Nexplanon | US8722037 | X-ray visible drug delivery device | Sep 28, 2027 | Organon |
| Nexplanon | US10821277 | Kit for and method of assembling an applicator for inserting an implant | May 31, 2027 | Organon |
| Nexplanon | US8888745 | Applicator for inserting an implant |
Aug 28, 2026
(Expired) | Organon |
Etonogestrel's Family Patents
Explore Our Curated Drug Screens
Clinical Trials
Recent Clinical Trials on Etonogestrel:
Sometimes companies keep conducting clinical trials even after the drug's approval to discover new formulations, methods of use, or new treatment indications, so they could file for additional patents or receive regulatory exclusivity extensions, such as pediatric exclusivity, potentially delaying generic competition. Based on these recent clinical trials, generic companies need to consider the potential for new intellectual property or regulatory hurdles. These strategic moves by the drug owner might delay generic substitution or lead to additional sales of the brand drug, even after patent expiry.
| Title | Lead Sponsor | Collaborators | Status | Phases |
|---|---|---|---|---|
 | ||||
| Long Term Evaluation of Scapular-inserted Contraceptive Implants | Yale University | NA |
RECRUITING
(Jul 1, 2026)
| PHASE2 |